CIK 0000318154 · Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953540776
- Phone
- (805)447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- 4 Grant or award SVP, Human Resources acquired 1,311 shares (grant or award)
- 4 Grant or award SVP, Business Development acquired 1,256 shares (grant or award)
- 4 Grant or award SVP & CCO acquired 1,954 shares (grant or award)
- 4 Grant or award EVP & CFO acquired 10,338 shares (grant or award)
- 4 Grant or award EVP & Gen. Counsel & Secy. acquired 11,760 shares (grant or award)
- 4 Grant or award EVP, Global Commercial Ops acquired 12,924 shares (grant or award)
- 4 Grant or award VP, Finance & CAO acquired 418 shares (grant or award)
- 4 Grant or award Chairman, CEO and President acquired 41,133 shares (grant or award)
- 10-K Report Annual Report
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award EVP, R&D, & Chief Sci. Officer acquired 22,393 shares (grant or award)
- 8-K Event Results of operations
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale SVP & CCO sold 2,096 shares at $273.03 ($572,276)
- 144 Insider Sale of Securities
- 4 Gift EVP, Research and Development gave 165 shares (gift)
- 4 Open-market sale EVP, Gen. Counsel & Secy. sold 10,000 shares at $272.81 ($2,728,136)
Page 18 of 161 · 3,201 filings